Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model

BMJ (Online)

Volumn 349, Issue , 2014, Pages

  Crider, Krista S ^a   Devine, Owen ^a   Hao, Ling ^b,c   Dowling, Nicole F ^a   Li, Song ^d   Molloy, Anne M ^e   Li, Zhu ^b   Zhu, Jianghui ^b,f   Berry, Robert J ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d PEKING UNIVERSITY THIRD HOSPITAL   (China)

^e TRINITY COLLEGE DUBLIN   (Ireland)

^f CHINA NATIONAL CENTER FOR FOOD SAFETY RISK ASSESSMENT   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FOLIC ACID;

ARTICLE; BAYES THEOREM; CELL POPULATION; CHINA; CHINESE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ERYTHROCYTE; FEMALE; FOLIC ACID BLOOD LEVEL; GESTATIONAL AGE; HIGH RISK PATIENT; HUMAN; NEURAL TUBE DEFECT; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SENSITIVITY ANALYSIS; VITAMIN SUPPLEMENTATION;

BAYES THEOREM; ERYTHROCYTES; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; GENOTYPE; HEMATINICS; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NEURAL TUBE DEFECTS; PREGNANCY; PRENATAL CARE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84904876075     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g4554     Document Type: Article

References (48)

1. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, et al. Prevention of neural-tube defects with folic acid in China: China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 1999;341:1485-90.
2. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;338:131-7.
3. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5. (Pubitemid 23003073)
4. Shibuya K, Murray CJL. Congenital anomalies. In: Murray CJ, Lopez AD, eds. Health dimensions of sex and reproduction. Harvard School of Public Health on behalf of the World Health Organization and the World Bank, 1998:455-512.
5. Cortes F, Mellado C, Pardo RA, Villarroel LA, Hertrampf E. Wheat flour fortification with folic acid: changes in neural tube defects rates in Chile. Am J Med Genet A 2012;158:1885-90.
6. De Wals P, Tairou F, Van Allen MI, Lowry RB, Evans JA, Van den Hof MC, et al. Spina bifida before and after folic acid fortification in Canada. Birth Defects Res A Clin Mol Teratol 2008;82:622-6.
7. Chen LT, Rivera MA. The Costa Rican experience: reduction of neural tube defects following food fortification programs. Nutr Rev 2004;62:S40-3. (Pubitemid 38916079)
8. Williams LJ, Mai CT, Edmonds LD, Shaw GM, Kirby RS, Hobbs CA, et al. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 2002;66:33-9. (Pubitemid 34734388)
9. Sayed AR, Bourne D, Pattinson R, Nixon J, Henderson B. Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa. Birth Defects Res A Clin Mol Teratol 2008;82:211-6. (Pubitemid 351657146)
10. Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;150:626-31.
11. Selhub J, Jacques PF, Dallal G, Choumenkovitch S, Rogers G. The use of blood concentrations of vitamins and their respective functional indicators to define folate and vitamin B12 status. Food Nutr Bull 2008;29(2 suppl):S67-73.
12. Wallingford JB, Niswander LA, Shaw GM, Finnell RH. The continuing challenge of understanding, preventing, and treating neural tube defects. Science 2013;339:1222002.
13. McMahon DM, Liu J, Zhang H, Torres ME, Best RG. Maternal obesity, folate intake, and neural tube defects in offspring. Birth Defects Res A Clin Mol Teratol 2013;97:115-22.
14. Agopian AJ, Tinker SC, Lupo PJ, Canfield MA, Mitchell LE, for the National Birth Defects Prevention Study. Proportion of neural tube defects attributable to known risk factors. Birth Defects Res A Clin Mol Teratol 2013;97:42-6.
15. Hao L, Yang Q-H, Li Z, Bailey LB, Zhu J-H, Hu DJ, et al. Folate status and homocysteine response to folic acid doses and withdrawal among young Chinese women in a large-scale randomized double-blind trial. Am J Clin Nutr 2008;88:448-57.
16. Cuskelly GJ, McNulty H, Scott JM. Fortification with low amounts of folic acid makes a significant difference in folate status in young women: implications for the prevention of neural tube defects. Am J Clin Nutr 1999;70:234-9. (Pubitemid 29347569)
17. Lamers Y, Prinz-Langenohl R, Bramswig S, Pietrzik K. Red blood cell folate concentrations increase more after supplementation with [6S]-5-methyltetrahydrofolate than with folic acid in women of childbearing age. Am J Clin Nutr 2006;84:156-61. (Pubitemid 44699180)
18. Hursthouse NA, Gray AR, Miller JC, Rose MC, Houghton LA. Folate status of reproductive age women and neural tube defect risk: the effect of long-term folic acid supplementation at doses of 140 microg and 400 microg per day. Nutrients 2011;3:49-62.
19. Norsworthy B, Skeaff CM, Adank C, Green TJ. Effects of once-a-week or daily folic acid supplementation on red blood cell folate concentrations in women. Eur J Clin Nutr 2004;58:548-54. (Pubitemid 38443716)
20. Green TJ, Skeaff CM, Rockell JE, Venn BJ. Folic acid fortified milk increases blood folate and lowers homocysteine concentration in women of childbearing age. Asia Pac J Clin Nutr 2005;14:173-8. (Pubitemid 40769788)
21. Adank C, Green TJ, Skeaff CM, Briars B. Weekly high-dose folic acid supplementation is effective in lowering serum homocysteine concentrations in women. Ann Nutr Metab 2003;47:55-9. (Pubitemid 36356918)
22. Daly S, Mills JL, Molloy AM, Conley M, Lee YJ, Kirke PN, et al. Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet 1997;350:1666-9. (Pubitemid 28036827)
23. Schorah CJ, Wild J, Hartley R, Sheppard S, Smithells RW. The effect of periconceptional supplementation on blood vitamin concentrations in women at recurrence risk for neural tube defect. Br J Nutr 1983;49:203-11. (Pubitemid 13082659)
24. Crider KS, Zhu JH, Hao L, Yang QH, Yang TP, Gindler J, et al. MTHFR 677C->T genotype is associated with folate and homocysteine concentrations in a large, population-based, double-blind trial of folic acid supplementation. Am J Clin Nutr 2011;93:1365-72.
25. Yan L, Zhao L, Long Y, Zou P, Ji G, Gu A, et al. Association of the maternal MTHFR C677T polymorphism with susceptibility to neural tube defects in offsprings: evidence from 25 case-control studies. PloS One 2012;7:e41689.
26. Zhang T, Lou J, Zhong R, Wu J, Zou L, Sun Y, et al. Genetic variants in the folate pathway and the risk of neural tube defects: a meta-analysis of the published literature. PloS One 2013;8:e59570.
27. De Wals P, Tairou F, Van Allen MI, Uh SH, Lowry RB, Sibbald B, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med 2007;357:135-42. (Pubitemid 47057731)
28. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects: implications for prevention. JAMA 1995;274:1698-702.
29. Hao L, Ma J, Stampfer MJ, Ren A, Tian Y, Tang Y, et al. Geographical, seasonal and gender differences in folate status among Chinese adults. J Nutr 2003;133:3630-35. (Pubitemid 37409499)
30. Mao R, Fan Y, Chen F, Sun D, Bai J, Fu S. Methylenetetrahydrofolate reductase gene polymorphisms in 13 Chinese ethnic populations. Cell Biochem Funct 2008;26:352-8. (Pubitemid 351613177)
31. Wilcken B, Bamforth F, Li Z, Zhu H, Ritvanen A, Renlund M, et al. Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet 2003;40:619-25. (Pubitemid 37046918)
32. O'Broin S, Kelleher B. Microbiological assay on microtitre plates of folate in serum and red cells. J Clin Pathol 1992;45:344-7.
33. Pfeiffer CM, Hughes JP, Lacher DA, Bailey RL, Berry RJ, Zhang M, et al. Estimation of trends in serum and RBC folate in the U.S. population from pre- to postfortification using assay - adjusted data from the NHANES 1988-2010. J Nutr 2012;142:886-93.
34. Branum AM, Bailey R, Singer BJ. Dietary supplement use and folate status during pregnancy in the United States. J Nutr 2013;143:486-92.
35. Pfeiffer CM, Zhang M, Lacher DA, Molloy AM, Tamura T, Yetley EA, et al. Comparison of serum and red blood cell folate microbiologic assays for national population surveys. J Nutr 2011;141:1402-9.
36. Holmes MV, Newcombe P, Hubacek JA, Sofat R, Ricketts SL, Cooper J, et al. Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. Lancet 2011;378:584-94.
37. Milman N, Byg KE, Hvas AM, Bergholt T, Eriksen L. Erythrocyte folate, plasma folate and plasma homocysteine during normal pregnancy and postpartum: a longitudinal study comprising 404 Danish women. Eur J Haematol 2006;76:200-5.
38. Ubeda N, Reyes L, Gonzalez-Medina A, Alonso-Aperte E, Varela-Moreiras G. Physiologic changes in homocysteine metabolism in pregnancy: a longitudinal study in Spain. Nutrition 2011;27:925-30.
39. Centers for Disease Control and Prevention (CDC). CDC Grand Rounds: additional opportunities to prevent neural tube defects with folic acid fortification. MMWR Morb Mortal Wkly Rep 2010;59:980-4.
40. Parker SE, Mai CT, Canfield MA, Rickard R, Wang Y, Meyer RE, et al. Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol 2010;88:1008-16.
41. Finer LB, Zolna MR. Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception 2011;84:478-85.
42. Tinker SC, Cogswell ME, Devine O, Berry RJ. Folic acid intake among U.S. women aged 15-44 years, National Health and Nutrition Examination Survey, 2003-2006. Am J Prev Med 2010;38:534-42.
43. Bestwick JP, Huttly WJ, Morris JK, Wald NJ. Prevention of neural tube defects: a cross-sectional study of the uptake of folic acid supplementation in nearly half a million women. PloS One 2014;9:e89354.
44. Nelson CR, Leon JA, Evans J. The relationship between awareness and supplementation: which Canadian women know about folic acid and how does that translate into use? Can J Public Health 2014;105:e40-6.
45. McDonnell R, Delany V, O'Mahony MT, Mullaney C, Lee B, Turner MJ. Neural tube defects in the Republic of Ireland in 2009-11. J Public Health (Oxf) 2014; published online 18 March.
46. Horn F, Sabova L, Pinterova E, Hornova J, Trnka J. Prevention of neural tube defects by folic acid - awareness among women of childbearing age in Slovakia. Bratisl Lek Listy 2014;115:91-7.
47. Bradbury KE, Williams SM, Green TJ, McMahon JA, Mann JI, Knight RG, et al. Differences in erythrocyte folate concentrations in older adults reached steady-state within one year in a two-year, controlled, 1 mg/d folate supplementation trial. J Nutr 2012;142:1633-7.
48. Yang Q, Cogswell ME, Hamner HC, Carriquiry A, Bailey LB, Pfeiffer CM, et al. Folic acid source, usual intake, and folate and vitamin B-12 status in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2006. Am J Clin Nutr 2010;91:64-72.